The FDA has approved a nasal spray for the treatment of migraines and Ochsner Health Neurologist Dr. Jose Posas said this is welcome news because there are more options than ever to give migraine sufferers relief.
“So, no one needs to suffer in silence. I tell my patients all the time you don’t get an award for suffering. So, if you’re hurting with a migraine go out and see a professional,” said Posas.
The nasal spray is called Zavegepant and in trials, 24 percent of patients reported they were pain-free in two hours and 40 percent were free of sensitivities, to things like light, sound, and even nausea.
Posas said the nasal spray is also ideal for heart patients who had to avoid other migraine meds that often tighten blood vessels.
“This newer agent does not do anything in regards to cardiac preexisting conditions. Heart patients who have migraines can be treated now instead of suffering,” said. Posas.
In addition to cardiac patients who can benefit from the nasal spray, Posas said patients who use preventative oral medications or even Botox to decrease the frequency of their migraine attacks.
“Or takes one of the other injectables, Emgality, Ajovy, or the Aimovig, this is something that won’t interact with those medications and in fact may be really helpful if the rescue medication isn’t currently working for them,” said Posas.
He said Zavegepant should begin rolling out to pharmacies in the near future
Comments